These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21785472)

  • 21. Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Invest Dermatol; 2016 Nov; 136(11):2158-2167. PubMed ID: 27424318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab as salvage therapy for refractory chronic GVHD.
    Mohty M; Marchetti N; El-Cheikh J; Faucher C; Fürst S; Blaise D
    Bone Marrow Transplant; 2008 May; 41(10):909-11. PubMed ID: 18278073
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
    Perales MA; Ishill N; Lomazow WA; Weinstock DM; Papadopoulos EB; Dastigir H; Chiu M; Boulad F; Castro-Malaspina HR; Heller G; Jakubowski AA; O'Reilly RJ; Small TN; Young JW; Kernan NA
    Bone Marrow Transplant; 2007 Sep; 40(5):481-6. PubMed ID: 17618322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation.
    Tardieu M; Rybojad M; Peffault de Latour R; Robin M; de Masson A; Xhaard A; Le Buanec H; Parquet N; Sicre de Fontbrune F; Bergeron A; Scieux C; Dessirier V; Bensussan A; Bagot M; Socié G; Bouaziz JD
    Blood; 2013 Jul; 122(3):463-5. PubMed ID: 23869081
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD.
    Magro L; Catteau B; Coiteux V; Bruno B; Jouet JP; Yakoub-Agha I
    Bone Marrow Transplant; 2008 Dec; 42(11):757-60. PubMed ID: 18762765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
    Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
    J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease.
    Calzavara Pinton P; Porta F; Izzi T; Venturini M; Capezzera R; Zane C; Notarangelo LD
    Haematologica; 2003 Oct; 88(10):1169-75. PubMed ID: 14555314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
    Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
    Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab in critically ill patients.
    Dimopoulos G; Armaganidis A; Poulakou G; Matthaiou DK
    Minerva Anestesiol; 2013 Feb; 79(2):185-93. PubMed ID: 23135691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges.
    White JM; Creamer D; du Vivier AW; Pagliuca A; Ho AY; Devereux S; Salisbury JR; Mufti GJ
    Br J Dermatol; 2007 May; 156(5):1032-8. PubMed ID: 17419693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
    Zhou H; Guo M; Bian C; Sun Z; Yang Z; Zeng Y; Ai H; Zhao RC
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of CD20 blockade in allogeneic hematopoietic cell transplantation.
    Kharfan-Dabaja MA; Bazarbachi A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1347-54. PubMed ID: 20083213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
    Baum S; Pavlotsky F; Shpiro D; Trau H
    Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
    [No Abstract]   [Full Text] [Related]  

  • 34. Complete remission of sclerodermatous cutaneous graft-versus-host disease after low-dose interleukine-2 treatment.
    Weiss M; de Masson A; Robin M; Peffault de Latour R; Bagot M; Socié G; Bouaziz JD
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e791-e793. PubMed ID: 32329912
    [No Abstract]   [Full Text] [Related]  

  • 35. Dermatological complications of chronic graft versus host disease.
    Raina V; Shafi M; Bakar MA
    J Assoc Physicians India; 1985 Jul; 33(7):494-6. PubMed ID: 4055673
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of refractory chronic GVHD with rituximab: a GITMO study.
    Zaja F; Bacigalupo A; Patriarca F; Stanzani M; Van Lint MT; Filì C; Scimè R; Milone G; Falda M; Vener C; Laszlo D; Alessandrino PE; Narni F; Sica S; Olivieri A; Sperotto A; Bosi A; Bonifazi F; Fanin R;
    Bone Marrow Transplant; 2007 Aug; 40(3):273-7. PubMed ID: 17549053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in refractory cutaneous polyarteritis.
    Krishnan S; Bhakuni DS; Kartik S
    Int J Rheum Dis; 2012 Oct; 15(5):e127. PubMed ID: 23083048
    [No Abstract]   [Full Text] [Related]  

  • 38. Sclerodermatous changes of chronic graft-versus-host-disease treated with puva.
    Woscoff A; Ruíz Lascano A; De Pablo AB; Robinson A
    Int J Dermatol; 1996 Sep; 35(9):656-8. PubMed ID: 8876297
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple morphea-like lesions associated with chronic graft-versus-host disease after cord blood transplantation.
    Kawakami Y; Ohtsuka M; Kikuta A; Yamamoto T
    Acta Derm Venereol; 2009; 89(1):86-7. PubMed ID: 19197550
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of chorionic gonadotropin in the treatment of phlebopathic dermatoses].
    Mian EU; Barachini P; Martini P
    Minerva Med; 1981 Feb; 72(4-5):193-203. PubMed ID: 7207843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.